Skip to main content
PatientsReferrer
 
Request Appointment

New PET-CT Service Opening November 2017 at Qscan Northlakes & Qscan Hobart

With great pride, Qscan Radiology Clinics announces the opening of their state-of-the-art PET-CT and oncology imaging service at Northlakes, Brisbane and Hobart, Tasmania. PET-CT (Positron Emission Tomography-Computed Tomography) facilitates early and more accurate detection of tumours, reducing the need for unnecessary surgery and increasing survival rates. The latest scanner from Siemens has been chosen for both the Qscan Northlakes & Qscan Hobart locations because of its unparalleled image quality, lowest radiation dose and optimised patient safety and comfort.   State-of-the-art technology reinforces Qscan’s reputation for excellence in imaging.  Our team at Qscan is continually striving to improve the level of service to our patients, referrers and the community. PET-CT is a premium technology with very significant clinical benefits for early detection and staging a variety of cancers.  PET-CT can detect and monitor cancer and other diseases due to the significantly increased sensitivity and clarity of images.  It will also significantly improve the treatment and provide more accurate tumour detection, as well as reduce the need for unnecessary surgery. All patients with Medicare eligible indications will be bulk billed, and scans interpreted by Qscan’s focussed team of highly trained subspecialty oncologic radiologists. Qscan Northlakes Clinic Details: Monday – Friday 9:00am – 5:00pm 9 McLennan Crt Northlakes QLD 4509 Ph: 07 3448 8840 Fax: 07 3880 6118 Qscan Hobart Clinic Details: Monday – Friday 9:00am – 5:00pm 2 Melville Street, Access via Campbell Street Hobart TAS 7000 Ph: 03 6240 1940 Fax: 03 6231 4985­

Latest news

We are excited to announce that Qscan Group’s newest clinic, Qscan Tweed City, is now open.

Qscan Group have today celebrated the opening of our newest clinic, Qscan Newstead.

Qscan Group have today celebrated the opening of our newest clinic Qscan Maroochydore, which will enhance healthcare accessibility and improve outcomes for regional cancer pati

Qscan Group are proud to have launched a new service which will enhance healthcare accessibility and improve outcomes for regional cancer patients.

Nerve root HCLA injections are essential for neuropathic pain, as they provide diagnostic and therapeutic benefits.